Andrew R. Clamp, PhD, on Gynecologic Cancers: Results of the ICON8 Trial

2017 ESMO Congress
Tweet this page

Andrew R. Clamp, PhD, of The Christie NHS Foundation Trust, discusses his phase III study findings on dose-dense chemotherapy integration in first-line treatment of epithelial ovarian, fallopian tube, and primary peritoneal carcinoma (Abstract 929O).

Advertisement

Advertisement



Advertisement